These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8085440)

  • 1. Meningeal carcinomatosis: CSF cytology, immunocytochemistry and biochemical tumor markers.
    Oschmann P; Kaps M; Völker J; Dorndorf W
    Acta Neurol Scand; 1994 May; 89(5):395-9. PubMed ID: 8085440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSF cytology versus immunocytochemistry in meningeal carcinomatosis.
    Boogerd W; Vroom TM; van Heerde P; Brutel de la Rivière G; Peterse JL; van der Sande JJ
    J Neurol Neurosurg Psychiatry; 1988 Jan; 51(1):142-5. PubMed ID: 2832546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytologic characteristics of meningeal carcinomatosis: increased diagnostic accuracy using carcinoembryonic antigen and epithelial membrane antigen immunocytochemistry.
    Jorda M; Ganjei-Azar P; Nadji M
    Arch Neurol; 1998 Feb; 55(2):181-4. PubMed ID: 9482359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurements of CSF biochemical tumor markers in patients with meningeal carcinomatosis and brain tumors.
    Nakagawa H; Kubo S; Murasawa A; Nakajima S; Nakajima Y; Izumoto S; Hayakawa T
    J Neurooncol; 1992 Feb; 12(2):111-20. PubMed ID: 1560255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical analysis of the cerebrospinal fluid for carcinomatous and lymphomatous leptomeningitis.
    Hovestadt A; Henzen-Logmans SC; Vecht CJ
    Br J Cancer; 1990 Oct; 62(4):653-4. PubMed ID: 2223585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid (CSF) cytology: current status and diagnostic applications.
    Bigner SH
    J Neuropathol Exp Neurol; 1992 May; 51(3):235-45. PubMed ID: 1583530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid tumour markers in patients treated for meningeal malignancy.
    van Zanten AP; Twijnstra A; Ongerboer de Visser BW; van Heerde P; Hart AA; Nooyen WJ
    J Neurol Neurosurg Psychiatry; 1991 Feb; 54(2):119-23. PubMed ID: 2019836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal Fluid Cytological Diagnosis in Multiple Myeloma With Leptomeningeal Involvement: A Report of Two Cases.
    Ren H; Zou Y; Zhao Y; Li J; Han X; He J; Guan H
    Diagn Cytopathol; 2017 Jan; 45(1):66-68. PubMed ID: 27628930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of lymphoma, leukemia, and metastatic tumor involvement of the cerebrospinal fluid by cytology and immunocytochemistry.
    Tani E; Costa I; Svedmyr E; Skoog L
    Diagn Cytopathol; 1995 Feb; 12(1):14-22. PubMed ID: 7789240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Meningeal carcinomatosis with a normal cell count and biochemistry in the cerebrospinal fluid].
    Cea-Calvo L; Bezares S; Berbel A; Ruiz-Morales J; González C
    Rev Clin Esp; 2000 Jan; 200(1):51-2. PubMed ID: 10721298
    [No Abstract]   [Full Text] [Related]  

  • 11. Cerebrospinal fluid cytology diagnosis of meningeal carcinomatosis in patients with small-cell carcinoma of the lung. A study of interobserver and intraobserver variability.
    Pedersen AG; Olsen J; Nasiell M
    Acta Cytol; 1986; 30(6):648-52. PubMed ID: 3024430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gadolinium-enhanced magnetic resonance imaging of meningeal carcinomatosis in colon cancer.
    Kato H; Emura S; Takashima T; Ohmori K; Sunaga T
    Tohoku J Exp Med; 1995 Jun; 176(2):121-6. PubMed ID: 7482522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant cells in cerebrospinal fluid (CSF): the meaning of a positive CSF cytology.
    Glass JP; Melamed M; Chernik NL; Posner JB
    Neurology; 1979 Oct; 29(10):1369-75. PubMed ID: 573381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central nervous system Hodgkin's disease relapsing with eosinophilic pleocytosis.
    Hauke RJ; Tarantolo SR; Bashir RM; Moravec D; Bierman PJ
    Leuk Lymphoma; 1996 Mar; 21(1-2):173-5. PubMed ID: 8907286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid cytology in patients with cancer: minimizing false-negative results.
    Glantz MJ; Cole BF; Glantz LK; Cobb J; Mills P; Lekos A; Walters BC; Recht LD
    Cancer; 1998 Feb; 82(4):733-9. PubMed ID: 9477107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the Utility of Cytology and Flow Cytometry of Cerebrospinal Fluid Samples in Clinical Practice.
    Nam AS; Giorgadze T; Tam W; Chadburn A
    Acta Cytol; 2018; 62(2):130-136. PubMed ID: 29510385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison between ventricular and lumbar cerebrospinal fluid cytology in adult patients with leptomeningeal metastases.
    Chamberlain MC; Kormanik PA; Glantz MJ
    Neuro Oncol; 2001 Jan; 3(1):42-5. PubMed ID: 11305416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the cerebrospinal fluid ctDNA detection by next-generation sequencing in the diagnosis of meningeal Carcinomatosis.
    Zhao Y; He JY; Zou YL; Guo XS; Cui JZ; Guo L; Bu H
    BMC Neurol; 2019 Dec; 19(1):331. PubMed ID: 31856745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meningeal carcinomatosis: origin of local IgG production in the CSF.
    Schipper HI; Bardosi A; Jacobi C; Felgenhauer K
    Neurology; 1988 Mar; 38(3):413-6. PubMed ID: 3347346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leptomeningeal carcinomatosis: review of the literature.
    Iaconetta G; Lamaida E; Rossi A; Signorelli F; Manto A; Giamundo A
    Acta Neurol (Napoli); 1994 Aug; 16(4):214-20. PubMed ID: 7856476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.